News

Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...
A study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.
Snack packaging's headed for a makeover in this state. If warnings take the fun out of possibly ingesting banned ingredients ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...
Abeona's ZEVASKYN approval and a $3.1 million price point are undervalued by the market. Find out why ABEO stock is a Buy.
The study, led by the U.S. Centers for Disease Control and Prevention (CDC), found that people who took bismuth subsalicylate ...